Latham & Watkins advised CHEPLAPHARM on the deal and on the bridge loan. CHEPLAPHARM Arzneimittel GmbH announced the acquisition of the worldwide commercial rights (excluding South Korea)...
This content is for Standard 1 Year members only. LoginJoin Now